Discover the latest findings on cancer immunotherapy and the role of TET2 gene in immune response for better treatment ...

Researchers in Class of 1942 Professor of Chemistry Matthew D. Shoulders' lab have uncovered a sinister hidden mechanism that ...

A new study led by Aaron Hobbs, Ph.D., and Rachel Burge, Ph.D., at MUSC Hollings Cancer Center, reveals why a specific gene ...

A Northwestern Medicine-led study published in the Journal of Clinical Investigation has uncovered why older individuals with ...

Researchers at the University of Oslo and Oslo University Hospital have developed a promising new immunotherapy targeting the CTNNB1 gene mutation associated with various aggressive cancers like lung ...

Scientists in South Korea have discovered that one of the most common malignant brain tumors in young adults may begin years ...

New research reveals that certain brain tumors may originate silently within normal brain cells long before a tumor forms.

IN THE POPULAR imagination, cancer starts with a mutation in the DNA of a normal cell. That mutation allows the cell to multiply uncontrollably, circumventing the body’s usual quality-control checks.

Emerging immunotherapies and targeted therapies take aim at recently identified biomarkers ...